The threshold has been in place for quite some years. I don't have the figures right now, but I would say that for maybe 10 years the threshold did not change at all. Then a couple of years ago, the government decided to increase the threshold so that it's now around 230 euro per year. I would say that the government's motives for that were that it was still at a fairly low level and there was a need to adjust to developments in general.
We have had different governments in the last mandate periods, and the new government, which is more left-wing, has decided on these reforms to lower the threshold for certain patient groups. There is no, I would say, political debate in Sweden as of now targeted toward the pharmaceutical benefit scheme and the copayment by patients in that direction. There are other debates when it comes to dental care, for example, as patients in Sweden pay much more for that. The political focus is more concerned with those areas.